NCT04420507

Brief Summary

The study aimed to clarify the characteristics of the intestinal and oral microbiome of Gestational Diabetes Mellitus(GDM) patients during the whole pregnancy, try to clarify the relationship between the microbiome and GDM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Last Updated

June 9, 2020

Status Verified

March 1, 2020

Enrollment Period

2 years

First QC Date

September 10, 2018

Last Update Submit

June 5, 2020

Conditions

Keywords

Gastrointestinal Microbiomepregnancygestational diabetes mellitus

Outcome Measures

Primary Outcomes (2)

  • the gut and oral microbiome of GDM patients during pregnancy

    The composition and species of gut and oral microbiome of GDM patients,separately in the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks).

    the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)

  • the gut and oral microbiome of healthy pregnant women

    The composition and species of gut and oral microbiome of healthy pregnant women ,separately in the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks).

    the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)

Secondary Outcomes (1)

  • The glucose level during pregnancy

    the first trimester(9-14 gestational weeks), the second trimester (24-28 gestational weeks) and the third trimester(32-37 gestational weeks)

Study Arms (2)

GDM group

pregnant women who are diagnosed after 75g OGTT test between 24\~27+6 gestational weeks

health group

pregnant women who pass the 75g OGTT test and aren't diagnosed as GDM, and also don't have any other conditions, like hypertensive disorders, IBD, gastrointestinal ulcer, and so on.

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant women who can ensure a regular prenatal check in the PUMCH OB clinic.

You may qualify if:

  • pregnant women
  • gestational age: before 13+6 weeks
  • regular prenatal care in PUMCH

You may not qualify if:

  • have medical history or current conditions: Gastrointestinal disorders, for example: Gastritis, gastric ulcer, inflammatory bowel disease; Hypertension; Diabetes; SLE or other severe CTD;
  • pregnant, combine with malignancy diseases;
  • pregnant, can't ensure regular prenatal check.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

Related Publications (4)

  • Edwards SM, Cunningham SA, Dunlop AL, Corwin EJ. The Maternal Gut Microbiome During Pregnancy. MCN Am J Matern Child Nurs. 2017 Nov/Dec;42(6):310-317. doi: 10.1097/NMC.0000000000000372.

  • Walker RW, Clemente JC, Peter I, Loos RJF. The prenatal gut microbiome: are we colonized with bacteria in utero? Pediatr Obes. 2017 Aug;12 Suppl 1(Suppl 1):3-17. doi: 10.1111/ijpo.12217. Epub 2017 Apr 26.

  • Jordan S, Baker B, Dunn A, Edwards S, Ferranti E, Mutic AD, Yang I, Rodriguez J. Maternal-Child Microbiome: Specimen Collection, Storage, and Implications for Research and Practice. Nurs Res. 2017 Mar/Apr;66(2):175-183. doi: 10.1097/NNR.0000000000000201.

  • Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016 Nov 3;167(4):915-932. doi: 10.1016/j.cell.2016.10.027.

Biospecimen

Retention: SAMPLES WITHOUT DNA

stool samples were collected from objects in 3 time points:the first trimester(9-14 gestational weeks), the second trimester(24-28 gestational weeks) and the third trimester(32-37 gestational weeks). All the samples were collected at home by the participants using a PSP Spin Stool DNA kit, and the genomic DNA was extracted. The researchers only amplified the hypervariable V4 region of the bacterial 16S rRNA genes.

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2018

First Posted

June 9, 2020

Study Start

May 15, 2017

Primary Completion

April 30, 2019

Study Completion

April 30, 2020

Last Updated

June 9, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations